journal article·2026-10

Construction and screening of an HOCl-activated phenolic prodrug platform for diabetic foot ulcer therapy

Muqing Dai, Siyi Ding, Zhiting Wu, Hanzhi Lu, Shuxin Peng, Shasha Wang, Xiaoqiang Wang, Xiaoxiao Liu, Fulun Li, Peng Wei, Tao Yi

Dyes and Pigments· Volume 253
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Wound Healing and Treatments · Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Acute Kidney Injury Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Diabetic foot ulcers and their recurrence10.1056/NEJMra1615439 ↗
2. Diabetic foot ulcers: a review10.1001/jama.2023.10578 ↗
3. Cellular and molecular basis of wound healing in diabetes10.1172/JCI32169 ↗
4. Challenges in the treatment of chronic wounds10.1089/wound.2015.0635 ↗
5. Causes, prevention, and management of diabetes-related foot ulcers10.1016/S2213-8587(24)00110-4 ↗
6. Definitions and criteria for diabetic foot disease10.1002/dmrr.3268 ↗
7. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis10.1080/07853890.2016.1231932 ↗
8. Mitochondrial dysfunction and oxidative stress in diabetic wound10.1002/jbt.23407 ↗
9. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process10.1111/iwj.12557 ↗
10. The role of oxidative stress and antioxidants in diabetic wound healing10.1155/2021/8852759 ↗
11. Healing of diabetic neuropathic foot ulcers receiving standard treatment in randomised controlled trials: a random effects meta-analysis10.1111/wrr.13237 ↗
12. Debridement of diabetic foot ulcers10.1089/wound.2021.0016 ↗
13. Update on management of diabetic foot ulcers10.1111/nyas.13569 ↗
14. Thou shall not heal: overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment10.1016/j.addr.2023.115120 ↗
15. Natural polyphenols as multi-targeted agents in diabetic foot ulcer: a comprehensive systematic review
16. Natural products in the treatment of diabetic foot infection10.1186/s40001-024-02255-y ↗
17. A systematic review and meta-analysis of the effect of thymol as an anti-inflammatory and wound healing agent10.1002/ptr.7541 ↗
18. Effects of Carvacrol, Thymol and essential oils containing such monoterpenes on wound healing: a systematic review10.1111/jphp.13054 ↗
19. In vitro hormetic effect investigation of thymol on human fibroblast and gastric adenocarcinoma cells10.3390/molecules25143270 ↗
20. Systemic availability and pharmacokinetics of thymol in humans10.1177/009127002401102678 ↗
21. Role of polyphenols, their nano-formulations, and biomaterials in diabetic wound healing
22. Prodrug strategies for targeted therapy triggered by reactive oxygen species10.1039/C9MD00169G ↗
23. Reactive-oxygen-species-responsive drug delivery systems: promises and challenges10.1002/advs.201600124 ↗
24. Cleavage and noncleavage chemistry in reactive oxygen species (ROS)-responsive materials for smart drug delivery10.1021/acs.bioconjchem.3c00476 ↗
25. The landscape of small-molecule prodrugs10.1038/s41573-024-00914-7 ↗
26. Stimuli-responsive hydrogels based on cascade reactions: a novel strategy to promote the efficient repair of diabetic wounds10.7150/thno.126282 ↗
27. Glucose-responsive hyaluronic acid/carboxymethyl chitosan-based hydrogel with on-demand berberine release for diabetic wound healing10.1016/j.ijbiomac.2025.149772 ↗
28. Recent advances in the local drug delivery systems for diabetic wound healing: a comprehensive review10.1208/s12249-025-03172-x ↗
29. Release of Amino- or carboxy-containing compounds triggered by HOCl: application for imaging and drug design10.1002/anie.201813648 ↗
30. Deformylation reaction-based probe for in vivo imaging of HOCl10.1039/C7SC03784H ↗
31. HOCl-Activated aggregation of gold nanoparticles for multimodality therapy of tumors10.1002/advs.202100074 ↗
32. A reactive oxygen species-triggerable theranostic prodrug system10.1016/j.jconrel.2024.10.054 ↗
33. A multivalent targeting strategy for developing reactive oxygen species-activated tumor-seeking probe to guide precise surgical resection10.1002/anie.202510441 ↗
34. HOCl-Activated reactive organic selenium delivery platform for alleviation of inflammation10.1021/acs.bioconjchem.2c00349 ↗
35. Single-component dual-functional autoboost strategy by dual photodynamic and Cyclooxygenase-2 inhibition for lung cancer and spinal metastasis10.1002/advs.202303981 ↗
36. A fluorescent probe operating under weak acidic conditions for the visualization of HOCl in solid tumors in vivo10.1007/s11426-020-9737-y ↗
37. Mitochondrial dysfunction in diabetic ulcers: pathophysiological mechanisms and targeted therapeutic strategies10.3389/fcell.2025.1625474 ↗
38. Targeting oxidative damage in diabetic foot ulcers: integrative strategies involving antioxidant drugs and nanotechnologies10.1093/burnst/tkaf020 ↗
39. Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers10.1016/j.celbio.2025.100020 ↗
40. Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases10.1016/j.biomaterials.2019.119292 ↗
41. Myeloperoxidase: a key regulator of neutrophil oxidant production10.1080/13510002.1997.11747085 ↗
42. Hypochlorous acid chemistry in Mammalian cells—influence on infection and role in various pathologies10.3390/ijms231810735 ↗
43. Myeloperoxidase: a target for new drug development?10.1038/sj.bjp.0707358 ↗
44. Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention10.3164/jcbn.11-006FR ↗
45. Myeloperoxidase in human neutrophil host defence10.1111/cmi.12312 ↗
46. A new-type HOCl-activatable fluorescent probe and its applications in water environment and biosystems10.1016/j.scitotenv.2022.156164 ↗
47. A lysosome-targeted near-infrared fluorescent probe for cell imaging of Cu2+10.1016/j.dyepig.2022.110472 ↗
48. Database of absorption and fluorescence spectra of >300 common compounds for use in PhotochemCAD10.1111/php.12860 ↗
49. Cellular and molecular actions of methylene blue in the nervous system10.1002/med.20177 ↗
51. Evaluation of topical methylene blue nanoemulsion for wound healing in diabetic mice10.1080/13880209.2023.2254341 ↗